According to Stoke Therapeutics's latest financial reports the company's current EPS (TTM) is -$2.53. In 2022 the company made an earnings per share (EPS) of -$2.60 a decrease over its 2021 EPS that were of -$2.33.
Year | EPS | Change |
---|---|---|
2023 (TTM) | -$2.53 | -2.69% |
2022 | -$2.60 | 11.59% |
2021 | -$2.33 | 49.36% |
2020 | -$1.56 | -32.14% |
2019 | -$2.30 | 331.68% |
2018 | -$0.53 |
Company | EPS | EPS differencediff. | Country |
---|---|---|---|
ORIC Pharmaceuticals
ORIC | -$2.18 | -13.83% | ๐บ๐ธ USA |